21 CFR 524.775

§ 524.775 Emodepside and praziquantel.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 524.775, § 524.775 Emodepside and praziquantel, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87581
Permanent ID: ys:prov:87581@1
SHA-256: d185ce222afe676c5c70320bc66516c10da10170b9ec8a00c6c8d59d8754ca31

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each milliliter of solution contains 21.4 milligrams (mg) emodepside and 85.7 mg praziquantel. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use in cats—(1) Amount. The recommended minimum dose is 1.36 mg/pound (lb) (3 mg/kilogram (kg)) emodepside and 5.45 mg/lb (12 mg/kg) praziquantel applied as a single topical dose. (2) Indications for use. For the treatment and control of hookworm infections caused by Ancylostoma tubaeforme (adults, immature adults, and fourth stage larvae), roundworm infections caused by Toxocara cati (adults and fourth stage larvae), and tapeworm infections caused by Dipylidium caninum (adults) and Taenia taeniaeformis (adults). (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.